Atypical matters in myeloid differentiation.
Locati M, Mantovani A, Bonecchi R
Nat Immunol. 18(7):711-712. doi: 10.1038/ni.3776
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.
Capoluongo ED
ESMO Open. 2022 Sep 23;7(5):100585. doi: 10.1016/j.esmoop.2022.100585
A comprehensive investigation of histotype-specific microRNA and their variants in Stage I epithelial ovarian cancers.
Velle A
Int J Cancer. 2023 Jan 17;152(9):1989-2001. doi: 10.1002/ijc.34408
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).
Biswas SK
Blood. 2005 Nov 3;107(5):2112-22.
An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode.
Doni A
J Exp Med. 2015 May 11;212(6):905-25. doi: 10.1084/jem.20141268
ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity.
Massara M
Nat Commun. 2018 Feb 14;9(1):676. doi: 10.1038/s41467-018-03080-8
ACKR2 contributes to pulmonary dysfunction by shaping CCL5:CCR5-dependent recruitment of lymphocytes during influenza A infection in mice.
Tavares LP
Am J Physiol Lung Cell Mol Physiol. 2020 Jan 29;318(4):L655-L670. doi: 10.1152/ajplung.00134.2019
Accurate encoding and decoding by single cells: amplitude versus frequency modulation.
Micali G
PLoS Comput Biol. 2015 Jun 1;11(6):e1004222. doi: 10.1371/journal.pcbi.1004222
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade.
Bonavita E
Immunity. 2020 Nov 20;53(6):1215-1229.e8. doi: 10.1016/j.immuni.2020.10.020
Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.
Pelly VS
Cancer Discov. 2021 May 24;11(10):2602-2619. doi: 10.1158/2159-8290.CD-20-1815